The ACR has released a summary of a new 2024 guideline for the screening, treatment, and management of Lupus Nephritis.

Young adults with chronic pelvic pain report a low quality of life compared to healthy individuals, with those of color having lower QOL.

Throughout 2024, the FDA issued new drug approvals and expanded treatment indications across various rheumatologic diseases.

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

Neck pain in patients with medication-overuse headache was linked to earlier headache onset, higher levels of anxiety and allodynia, and poorer QOL.

Frailty is shown to be associated with lower bone mineral density (BMD) in the total hip among a predominantly male cohort of ...

The use of SGLT2 inhibitors vs GLP-1 receptor agonists was linked to a reduced risk for ULT and colchicine initiation among ...

Deucravacitinib outperformed placebo for treating moderate to severe scalp psoriasis, even among patients with less extensive ...

Between 2000 and 2022, NSAID prescription rates decreased among patients with IBD; opioid prescribing was more common.

Fatigue appears to play a key role in co-occurrence and maintenance of pain interference and sleep disturbance over time in pediatric chronic pain.

Researchers evaluated the prevalence of and risk factors for neuropathic pain among patients with spondyloarthritis.

The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine treatment for children ...